The European Medicines Agency re-examined clinical data of a subset of patients with one or no copies of the APOE4 gene ...

In honor of National Caregivers Month (November), we connected with Crystal Williams, associate vice president and assistant ...

Roche Holding AG is extremely optimistic that its latest experimental Alzheimer’s drug will deliver a benefit for patients, Chief Executive Officer Thomas Schinecker said, despite a track record of ...

November is Alzheimer’s Awareness Month. According to the Alzheimer’s Association Mississippi Chapter, nearly 7 million ...

Researchers have revealed the role of enzyme TYK2 in the aggregation of tau proteins, which contributes to Alzheimer’s ...

November is Alzheimer’s Awareness Month and New York has the second highest rate of Alzheimer’s disease in the U.S. NYC’s ...

New research highlights middle age as a pivotal period for brain health, with significant changes in how cells remove damaged mitochondria. Defects in this recycling process have been linked to ...

Researchers have identified two neural circuits in the retrosplenial cortex (RSC) that are critical for spatial navigation ...

Scientists say they have achieved a "first" in the development of drugs to treat Alzheimer's disease. Scientists say they ...

Alzheimer’s disease is the most common brain condition in older adults worldwide and a leading cause of dementia. Despite ...

We are making progress in the fight against Alzheimer’s disease. The human brain is complex, but prioritizing Alzheimer’s ...